Abbott's Libre Duo 10 Day becomes first US-approved wearable to monitor both glucose and ketones to combat diabetic ketoacidosis

Abbott has secured US FDA approval for its innovative Libre Duo 10 Day, a wearable sensor that continuously tracks glucose and ketones, aiming to enhance diabetic ketoacidosis prevention across all ages. Abbott has won US Food and Drug Administration authorisation…















